Accessibility Menu
 
Ekf Diagnostics Plc logo

Ekf Diagnostics Plc

(LSE) EKF

Current Price$24.90
Market Cap$10.43B
Since IPO (2002)-21%
5 Year-70%
1 Year+12%
1 Month-8%

Ekf Diagnostics Plc Financials at a Glance

Market Cap

$10.43B

Revenue (TTM)

$101.76M

Net Income (TTM)

$8.36M

EPS (TTM)

$0.47

P/E Ratio

51.49

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$24.90

Volume

179,382

Open

$24.90

Previous Close

$24.90

Daily Range

$23.54 - $24.90

52-Week Range

$19.00 - $31.90

EKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ekf Diagnostics Plc

Industry

Healthcare Equipment and Supplies

Employees

303

CEO

Gavin Joseph Jones

Headquarters

Cardiff, CF64 2EZ, GB

EKF Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

13%

Net Income Margin

4%

Return on Equity

3%

Return on Capital

9%

Return on Assets

3%

Earnings Yield

1.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.43B

Shares Outstanding

430.90M

Volume

179.38K

Short Interest

0.00%

Avg. Volume

441.58K

Financials (TTM)

Gross Profit

$26.48M

Operating Income

$6.75M

EBITDA

$6.75M

Operating Cash Flow

$9.71M

Capital Expenditure

$1.53M

Free Cash Flow

$8.18M

Cash & ST Invst.

$15.83M

Total Debt

$1.39M

Ekf Diagnostics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$26.32M

+2.3%

Gross Profit

$13.81M

+11.2%

Gross Margin

52.46%

N/A

Market Cap

$10.43B

N/A

Market Cap/Employee

$34.42M

N/A

Employees

303

N/A

Net Income

$178.00K

-93.4%

EBITDA

$6.47M

+46.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.45M

+298.4%

Accounts Receivable

$6.74M

-20.8%

Inventory

$8.30M

-5.3%

Long Term Debt

$987.00K

+59.7%

Short Term Debt

$398.00K

-88.6%

Return on Assets

2.62%

N/A

Return on Invested Capital

9.15%

N/A

Free Cash Flow

$3.74M

+1095.8%

Operating Cash Flow

$4.79M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TSTL.LTristel PLC
$382.50-0.65%
DXRX.LDiaceutics PLC
$161.50+0.00%
SCLP.LScancell Holdings plc
$12.50+2.04%
STX.LShield Therapeutics plc
$9.44+6.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About EKF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.